Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Publications
-
Unlocking cancer vaccine potential: What are the key factors?
Journal article
Grant M. et al, (2024), Human vaccines & immunotherapeutics, 20
-
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study
Journal article
Perez-Campuzano V. et al, (2024), JHEP Reports, 6
-
INCA033989: the first shot on goal for MPNs?
Journal article
Benlabiod C. and Psaila B., (2024), Blood, 144, 2278 - 2279
Seminars
